´
E.G. Lavoie et al. / Biochemical Pharmacology 67 (2004) 1917–1926
1925
The hydrolysis of ATP and UTP by mouse NTPDase3
showed a transient accumulation of the corresponding
diphosphonucleoside (ADP and/or UDP). When the level
of triphosphonucleoside(s) had sufficiently decreased, then
AMP or UMP accumulated in the medium (Fig. 6B and D).
This is in agreement with the measured kinetic constants of
mouse NTPDase3. The apparent Km for ATP and UTP
were half as much as the corresponding diphosphonucleo-
side (Table 2). In comparison, NTPDase1 hydrolyzes ATP
to AMP, one Pi at a time, without any accumulation of
ADP. In contrast, NTPDase2 hydrolyzes preferentially
ATP to ADP, the latter being a poor substrate of the
enzyme. The pattern of hydrolysis of NTPDase3 is some-
what in between the one of NTPDase1 and NTPDase2 [8].
For NTPDase1, the apparent Kms are similar for ATP and
ADP, in the order of 10 mM [36,37]. For human NTPDases
2 and 3 these constants are in the high micromolar range.
Hence, for intact NIH-3T3 cells stably transfected with
NTPDase2, the apparent Kms were around 400 mM for ATP
and 100 mM for ADP with apparent Vmaxs of 107 and of
4 nmol Pi/min per 106 cells, respectively [7]. The apparent
Kms of human NTPDase3 for ATP and ADP, evaluated
from protein extracts of transiently transfected COS-1
cells, were 128 and 96 mM, respectively, with apparent
Vmaxs of 2.0 and 0.5 mmol Pi/min/mg of protein [27].
The plasma membrane bound NTPDases 1–3 and 8
control the nucleotide levels in extracellular spaces, and
therefore, modulate P2 receptor signaling. The difference
in the biochemical and kinetic properties of these ectonu-
cleotidases may have profound physiological effects. The
affinity of the substrates toward the enzymes, the specific
activity and the products formed may determine distinct
roles for each plasma membrane bound NTPDase. For
example, we have recently shown that the different hydro-
lysis patterns of NTPDase1 and NTPDase2 dictated their
opposing roles in the control of platelet aggregation, as
demonstrated in vitro [38]. The AMP generated by
NTPDases, can then be further hydrolyzed by the ecto-
50-nucleotidase to adenosine. Thus, the hydrolysis products
of ATP (ADP and adenosine) react with different subtypes
of P2 and P1 receptors and trigger different physiological
actions.
Research (CIHR; MOP-49460 and M2C-50334) and from
´ ´
the ‘‘Fonds de la Recherche en Sante du Quebec’’ (FRSQ;
2822) to J.S.
References
[1] Zimmermann H. Ectonucleosides: some recent developments and a
note on nomenclature. Drug Dev Res 2001;52:44–56.
[2] Vasconcelos EG, Ferreira ST, de Carvalho TMU, de Souza W, Kettlun
AM, Mancilla M, et al. Partial purification of ATP diphosphohydro-
lase from Schistosoma mansoni. J Biol Chem 1996;271:22139–45.
´
[3] Schulte AM, Esch II J, Sevigny J, Kaczmarek E, Siegel JB, Imai M,
et al. Structural elements and limited proteolysis of CD39 influence
ATP diphosphohydrolase activity. Biochemistry 1999;38:2248–58.
[4] Handa M, Guidotti G. Purification and cloning of a soluble ATP-
diphosphohydrolase (apyrase) from potato tubers (Solanum tubero-
sum). Biochem Biophys Res Commun 1996;218:916–23.
[5] Wang TF, Guidotti G. CD39 is an ecto-(Ca2þ, Mg2þ)-apyrase. J Biol
Chem 1996;271:9898–901.
´
[6] Kaczmarek E, Koziak K, Sevigny J, Siegel JB, Anrather J, Beaudoin
AR, Bach FH, Robson SC. Identification and characterization of
CD39 vascular ATP diphosphohydrolase. J Biol Chem 1996;271:
33116–22.
[7] Mateo J, Harden TK, Boyer JL. Functional expression of a cDNA
encoding a human ecto-ATPase. Br J Pharmacol 1999;128:396–402.
[8] Kegel B, Braun N, Heine P, Maliszewski CR, Zimmermann H. An
ecto-ATPase and an ecto-ATP diphosphohydrolase are expressed in rat
brain. Neuropharmacology 1997;36:1189–200.
[9] Smith TM, Kirley TL. Cloning, sequencing, and expression of a
human brain ecto-apyrase related to both the ecto-ATPases and
CD39 ecto-apyrases. Biochim Biophys Acta 1998;1386:65–78.
[10] Chadwick BP, Frischauf AM. The CD39-like gene family—identifi-
cation of three new human members (CD39L2, CD39L3, and
CD39L4) their murine homologues, and a member of the gene family
from drosophila melanogaster. Genomics 1998;50:357–67.
´
[11] Bigonnesse F, Levesque SA, Kukulski F, Lecka J, Robson SC,
´
Fernandes MJG, Sevigny J. Cloning and characterization of mouse
nucleoside triphosphate diphosphohydrolase-8. Biochemistry, in
press.
[12] Wang TF, Guidotti G. Golgi localization and functional expression of
human uridine diphosphatase. J Biol Chem 1998;273:11392–9.
[13] Biederbick A, Rose S, Elsasser HP. A human intracellular apyrase-like
protein LALP70, localizes to lysosomal/autophagic vacuoles. J Cell
Sci 1999;112:2473–84.
[14] Biederbick A, Kosan C, Kunz J, Elsasser HP. First apyrase splice
variants have different enzymatic properties. J Biol Chem 2000;275:
19018–24.
[15] Mulero JJ, Yeung G, Nelken ST, Ford JE. CD39-L4 is a secreted
human apyrase, specific for the hydrolysis of nucleoside diphospha-
tases. J Biol Chem 1999;274:20064–7.
In summary, the distinct biochemical properties of
mouse NTPDase3 suggest that it controls extracellular
nucleotide levels differently than other ectonucleotidases,
including NTPDases 1 and 2, and would therefore regulate
P2 receptor activation in a distinctive manner. Future work
on the cellular localization and expression pattern of the
enzyme shall help define its potential function.
[16] Yeung G, Mulero JJ, McGowan DW, Bajwa SS, Ford JE. CD39L2, a
gene encoding a human nucleoside diphosphatase, predominantly
expressed in the heart. Biochemistry 2000;39:12916–23.
[17] Hicks-Berger CA, Chadwick BP, Frischauf AM, Kirley TL. Expres-
sion and characterization of soluble and membrane-bound human
nucleoside triphosphate diphosphohydrolase 6 (CD39L2). J Biol
Chem 2000;275:34041–5.
[18] Braun N, Fengler S, Ebeling C, Servos J, Zimmermann H. Sequencing,
functional expression and characterization of rat NTPDase6, a nucleo-
side diphosphatase and novel member of the ecto-nucleoside tripho-
sphate diphosphohydrolase family. Biochem J 2000;351:639–47.
[19] Shi JD, Kukar T, Wang CY, Li QZ, Cruz PE, Davoodi-Semiromi A,
et al. Molecular cloning and characterization of a novel mammalian
endo-apyrase (LALP1). J Biol Chem 2001;276:17474–8.
Acknowledgments
We thank Mrs. Julie Pelletier and Mr. Franc¸ois Bigon-
nesse for their technical assistance. This work was sup-
ported by grants from the Canadian Institutes of Health